Renal sympathetic nerves play a crucial role in the pathogenesis of hypertension, and renal denervation (RDN) is a new solution for patients with refractory hypertension. However, current RDN techniques show inconsistent results in clinical application probably owing to incomplete endovascular ablation of the sympathetic nerves and a lack of measures to localize and assess efficacy. In this study, a closed‐loop RDN system consisting of a sensing unit with a piezoelectric thin‐film sensor (PTFS) and a treatment unit with a hollow Pd nanoparticle shell (PdNPS) with a diameter of 202.0 nm for photothermal neural ablation is constructed. The PTFS can monitor and collect arterial pulsation and blood pressure (BP) and direct PdNPS to maximize RDN. PdNPS maintains a local temperature of 58–62 °C under near‐infrared‐II irradiation (1,064 nm) to achieve effective RDN within a range of 90–120 s treatment window. Photothermal ablation significantly inhibits the activities of renal sympathetic nerves post‐procedure and after one month and reduces the elevation of BP by > 50%. The novel closed‐loop system enables safe and efficient targeting, dynamic monitoring, and ablation of the renal sympathetic nerves. This closed‐loop system provides a new strategy for RDN technology and even for treating sympathetic nerve‐related chronic diseases.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: